Press releases

(November 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $750 million aggregate principal amount of its senior notes under the Company

(November 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, randomized,...

and Vancouver, B.C. (November 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP) announced today that they have jointly received the...

(November 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that the Centers for Medicare and Medicaid Services (CMS) has approved its application for a new series of...

(October 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Sixteenth Annual Healthcare Conference, which is being held November 7-9 in...

(October 25, 2005)

(October 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has acquired a portfolio of proprietary endoscopic stent technologies from Willy Rüsch GmbH (Rüsch), a...

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from the transitional phase of its OLYMPIA registry. The OLYMPIA registry is...

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the...

and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of...